Report: Sean Parker and Peter Thiel back cancer immunotherapy startup 3T Biosciences – MedCity News
MedCity News |
Report: Sean Parker and Peter Thiel back cancer immunotherapy startup 3T Biosciences
MedCity News One year after setting up a $250 million institute devoted to cancer immunotherapy, Sean Parker has backed 3T Biosciences alongside fellow billionaire investor Peter Thiel. Both were part of a $12 million + funding round for the stealth immunotherapy … |
